Critical Review of Clinical Trials of Bone Marrow Stem Cells in Liver Disease

Gastroenterology

Volumn 135, Issue 2, 2008, Pages 438-450

  Houlihan, Diarmaid Dominic ^a   Newsome, Philip Noel ^a  

^a MRC Centre for Immune Regulation   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ALCOHOL LIVER CIRRHOSIS; ARTICLE; BONE MARROW CELL; CELL FATE; CELL MOTILITY; CELL POPULATION; CELL TYPE; CHRONIC LIVER DISEASE; CLINICAL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; DEGRADATION; EX VIVO STUDY; FEVER; FIBROGENESIS; HEMATOPOIETIC STEM CELL; HUMAN; INFUSION; INJECTION SITE PAIN; LIVER; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER REGENERATION; LIVER RESECTION; NAUSEA; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RASH; RODENT; SPLENOMEGALY; STEM CELL TRANSPLANTATION;

EID: 48549100695     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.05.040     Document Type: Article

References (105)

1. Petersen B.E., Bowen W.C., Patrene K.D., et al. Bone marrow as a potential source of hepatic oval cells. Science 284 (1999) 1168-1170
2. Weissman I.L. Stem cells: units of development, units of regeneration and units in evolution. Cell 100 (2000) 157-168
3. Blau H.M., Brazelton T.R., and Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 105 (2001) 829-841
4. Korbling M., and Estrov Z. Adult stem cells for tissue repair-a new therapeutic concept?. N Engl J Med 349 (2003) 570-582
5. Orlic D. Adult bone marrow cells regenerate myocardium in ischemic heart disease. Ann N Y Acad Sci 996 (2003) 152-157
6. Overturf K., Al-Dhalimy M., Ou C.N., et al. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 151 (1997) 1273-1280
7. Rhim J.A., Sandgren E.P., Degen J.L., et al. Replacement of diseased mouse liver by hepatic cell transplantation. Science 263 (1994) 1149-1152
8. Wiemann S.U., Satyanarayana A., Tsahuridu M., et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 16 (2002) 935-942
9. Murphy F., and Iredale J. The telomere hypothesis for progressive liver cirrhosis. J Hepatol 38 (2003) 378-379
10. Braun K.M., and Sandgren E.P. Cellular origin of regenerating parenchyma in a mouse model of severe hepatic injury. Am J Pathol 157 (2000) 561-569
11. Newsome P.N., Hussain M.A., and Theise N.D. Hepatic oval cells: helping redefine a paradigm in stem cell biology. Curr Top Dev Biol 61 (2004) 1-128
12. Petersen B.E., Zajac V.F., and Michalopoulos G.K. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 27 (1998) 1030-1038
13. Gordon G.J., Coleman W.B., Hixson D.C., et al. Liver regeneration in rats with retrorsine-induced hepatocellular injury proceeds through a novel cellular response. Am J Pathol 156 (2000) 607-619
14. Oh S.H., Witek R.P., Bae S.H., et al. Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Gastroenterology 132 (2007) 1077-1087
15. Wulf G.G., Luo K.L., Jackson K.A., et al. Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells. Haematologica 88 (2003) 368-378
16. Wang X., Foster M., Al-Dhalimy M., et al. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A 100 (2003) 11881-11888
17. Menthena A., Deb N., Oertel M., et al. Bone marrow progenitors are not the source of expanding oval cells in injured liver. Stem Cells 22 (2004) 1049-1061
18. Newsome P.N., Johannessen I., Boyle S., et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 124 (2003) 1891-1900
19. Theise N.D., Nimmakayalu M., Gardner R., et al. Liver from bone marrow in humans. Hepatology 32 (2000) 11-16
20. Korbling M., Katz R.L., Khanna A., et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 346 (2002) 738-746
21. Alison M.R., Poulsom R., Jeffery R., et al. Hepatocytes from non-hepatic adult stem cells. Nature 406 (2000) 257
22. Theise N.D., Badve S., Saxena R., et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloblation. Hepatology 31 (2000) 235-240
23. Krause D.S., Theise N.D., Collector M.I., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 (2001) 369-377
24. Avital I., Inderbitzin D., Aoki T., et al. Isolation, characterisation and transplantation of bone marrow-derived hepatocyte stem cells. Biochem Biophys Res Commun 288 (2001) 156-164
25. Mallet V.O., Mitchell C., Mezey E., et al. Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo. Hepatology 35 (2002) 799-804
26. Lagasse E., Connors H., Al-Dhalimy M., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6 (2000) 1229-1234
27. Vassilopoulos G., Wang P.R., and Russell D.W. Transplanted bone marrow regenerates liver by cell fusion. Nature 422 (2003) 901-904
28. Wang X., Willenbring H., Akkari Y., et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422 (2003) 897-901
29. Ferrari G., Cusella-De Angelis G., Coletta M., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
30. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infracted myocardium. Nature 410 (2001) 701-705
31. Quintana-Bustamante O., Alvarez-Barrientos A., Kofman A.V., et al. Hematopoietic mobilisation in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion. Hepatology 43 (2006) 108-116
32. Takezawa R., Watanabe Y., and Akaike T. Direct evidence of macrophage differentiation from bone marrow cells in the liver: a possible origin of Kupffer cells. J Biochem (Tokyo) 118 (1995) 1175-1183
33. Russo F.P., Alison M.R., Bigger B.W., et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130 (2006) 1807-1821
34. Kisseleva T., Uchinami H., Feirt N., et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45 (2006) 429-438
35. Sakaida I., Terai S., Yamamoto N., et al. Transplantation of bone marrow cells reduces CCL4-induced liver fibrosis in mice. Hepatology 40 (2004) 1304-1311
36. Fang B., Shi M., Liao L., et al. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78 (2004) 83-88
37. Zhao D.C., Lei J.X., Chen R., et al. Bone marrow derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 11 (2005) 3431-3440
38. Oyagi S., Hirose M., Kojima M., et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 44 (2006) 742-748
39. Gaia S., Smedile A., Omede P., et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 45 (2006) 13-19
40. Terai S., Ishikawa T., Omori K., et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24 (2006) 2292-2298
41. Mohamadnejad M., Namiri M., Bagheri M., et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 28 (2007) 3359-3363
42. Mohamadnejad M., Alimoghaddam K., Mohyeddin-Bonab M., et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 10 (2007) 459-466
43. Lyra A.C., Soares M.B., da Silva L.F., et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 13 (2007) 1067-1073
44. Lyra A.C., Soares M.B., da Silva L.F., et al. A pilot randomised controlled study used to evaluate efficacy of autologous bone marrow mononuclear cells transplantation in patients with advanced chronic liver disease. Hepatology 46 Suppl 1 (2007) 271A (abstr)
45. Gordon M.Y., Levicar N., Pai M., et al. Characterisation and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 24 (2006) 1822-1830
46. + cells in patients with chronic liver disease. Cell Prolif 41 (2008) 115-125
47. Yannaki E., Anagnostopoulos A., Kapetanos D., et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol 34 (2006) 1583-1587
48. am Esch II J.S., Knoefel W.T., Klein M., et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 23 (2005) 463-470
49. Furst G., Schulte am Esch J., Poll L.W., et al. Portal vein embolisation and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology 243 (2007) 171-179
50. Jang Y.Y., Collector M.I., Baylin S.B., et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 6 (2004) 532-539
51. Fassett J.T., Tolbot D., Nelsen C.J., et al. The role of collagen structure in mitogen stimulation of ERK, cyclin D1 expression, and G1-S progression in rat hepatocytes. J Biol Chem 278 (2003) 31691-31700
52. Fassett J., Tolbot D., and Hansen L.K. Type I collagen structure regulates cell morphology and EGF signalling in primary rat hepatocytes through cAMP-dependant protein kinase A. Mol Biol Cell 17 (2006) 345-356
53. Trak-Smayra V., Contreras J., Dondero F., et al. Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation. Transplantation 77 (2004) 1755-1760
54. Taniguchi E., Kin M., Torimura T., et al. Endothelial progenitor cell transplantation improves the survival following liver injury in mice. Gastroenterology 130 (2006) 521-531
55. Nakamura T., Torimura T., Sakamoto M., et al. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 133 (2007) 91-107
56. Ueno T., Nakamura T., Torimura T., et al. Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol 39 (2006) 16-21
57. Payne C., Samuel K., Pryde A., et al. The impact of bone marrow stem cells on liver fibrosis in critically determined by their route of cell trafficking. Hepatology 46 (2007) 710A
58. Banas A., Teratani T., Yamamoto Y., et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46 (2007) 219-228
59. Wynter E.A., Buck D., Hart C., et al. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16 (1998) 387-396
60. Kucia M., Reca R., Campbell F.R., et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1Oct-4(+) stem cells identified in adult bone marrow. Leukemia 20 (2006) 857-869
61. Kucia M., Halasa M., Wysoczynski M., et al. Morphological and molecular characterisation of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 21 (2007) 297-303
62. Dominici M., Le Blanc K., Mueller I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006) 315-317
63. Wagner W., and Ho A.D. Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev 3 (2007) 239-248
64. Ikeda E., Yagi K., Kojima M., et al. Multipotent cells from the human third molar: feasibility of cell-based therapy for liver disease. Differentiation 76 (2008) 495-505
65. Tamagawa T., Oi S., Ishiwata I., et al. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell 20 (2007) 77-84
66. Najimi M., Khuu D.N., Lysy P.A., et al. Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes?. Cell Transplant 16 (2007) 717-728
67. Sato Y., Araki H., Kato J., et al. Human mesenchymal stem cells xenografted directly to rat are differentiated into human hepatocytes without fusion. Blood 106 (2005) 756-763
68. Piscaglia A.C., Shupe T.D., Oh S.H., et al. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 133 (2007) 619-631
69. Yannaki E., Athanasiou E., Xagorari A., et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Haematol 33 (2005) 108-119
70. Nauta A.J., and Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110 (2007) 3499-3506
71. Ren G., Zhang L., Zhao X., et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted actions of chemokines and nitric oxide. Cell Stem Cell 2 (2008) 141-150
72. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
73. Prochymal Crohn's Disease Phase II Clinical Trial Data. http://www.osiris.com Accessed 29 June 2008
74. Mazhari R., and Hare J.M. Advances in cell-based therapy for structural heart disease. Prog Cardiovasc Dis 49 (2007) 387-395
75. Christoforou N., and Gearhart J.D. Stem cells and their potential in cell-based cardiac therapies. Prog Cardiovasc Dis 49 (2007) 396-413
76. Liu F., Pan X., Chen G., et al. Hematopoietic stem cells mobilized by granulocyte colony-stimulating factor partly contribute to liver graft regeneration after partial orthotopic liver transplantation. Liver Transpl 12 (2006) 1129-1137
77. Gehling U.M., Willems M., Dandri M., et al. Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. J Hepatol 43 (2005) 845-853
78. Giron-Gonzalez J.A., Martinez-Sierra C., Rodriguez-Ramos C., et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 24 (2004) 437-445
79. Genesca J., Gonzalez A., Segura R., et al. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 94 (1999) 169-177
80. Yan L., Han Y., He Y., et al. Cell tracing techniques in stem cell transplantation. Stem Cell Rev 3 (2007) 265-269
81. Kiel M.J., He S., Ashkenazi R., et al. Haemopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU. Nature 449 (2007) 238-242
82. Svilvassy S.J., Meyerrose T.E., Ragland P.L., et al. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 98 (2001) 2108-2115
83. Zhan Y., Wang Y., Wei L., et al. Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats. Transplantation Proc 38 (2006) 3082-3085
84. Modo M., Cash D., Mellodew K., et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 17 (2002) 803-811
85. Amsalem Y., Mardor Y., Feinberg M.S., et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infracted myocardium. Circulation 116 (2007) I38-I145
86. Caveliers V., De Keulenaer G., Everaert H., et al. In vivo visualisation of 111In labelled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischaemic heart disease. Q J Nucl Med Mol Imaging 51 (2007) 61-66
87. Gao J., Dennis J.E., Muzic R.F., et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169 (2001) 12-20
88. Dalakas E., Newsome P.N., Harrison D.J., et al. Hematopoietic stem cell trafficking in liver injury. FASEB J 19 (2005) 1225-1231
89. Cassiman D., Barlow A., Vander Borght S., et al. Hepatic stellate cells do not derive from the neural crest. J Hepatol 44 (2006) 1098-1104
90. Wu X.Z., and Chen D. Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol 21 (2006) 1093-1098
91. Dumble M.L., Croager E.J., Yeoh G.C., et al. Generation and characterisation of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 23 (2002) 435-445
92. Becker R., Luthgens B., Oesch F., et al. Ha-rasVal12 but not p53ser247 leads to a significant neoplastic transformation rate of the putative rat liver stem cells (oval cell). Carcinogenesis 17 (1996) 2635-2640
93. Rubio D., Garcia-Castro J., Martín M.C., et al. Spontaneous human adult stem cell transformation. Cancer Res 65 (2005) 3035-3039
94. Serakinci N., Guldberg P., Burns J.S., et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23 (2004) 5095-5098
95. Hsieh C.B., Chen C.J., Chen T.W., et al. Accuracy of indocyanine green pulse spectrophotometry clearance test for liver function prediction in transplanted patients. World J Gastroenterol 15 (2004) 2394-2396
96. Horn K.D., Wax P., Schneider S.M., et al. Biomarkers of liver regeneration allow early prediction of hepatic recovery after acute necrosis. Am J Clin Pathol 112 (1999) 351-357
97. Assy N., Gong Y., Zhang M., et al. Use of proliferating cell nuclear antigen as a marker of liver regeneration after partial hepatectomy in rats. J Lab Clin Med 131 (1998) 251-256
98. Bockhorn M., Goralski M., Prokofiev D., et al. VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res 138 (2007) 291-299
99. Streetz K.L., Luedde T., Manns M.P., et al. Interleukin 6 and liver regeneration. Gut 47 (2000) 309-312
100. Dinant S., Vetelainen R.L., Florquin S., et al. Il-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J Surg Res 141 (2007) 176-182
101. Campbell J.S., Prichard L., Schaper F., et al. Expression of suppressors of cytokine signalling during liver regeneration. J Clin Invest 107 (2001) 1285-1292
102. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
103. Regev A., Berho M., Jeffers L.J., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002) 2614-2618
104. Rosenberg W.M., Voelker M., Thiel R., et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127 (2004) 1704-1713
105. Guha I.N., Parkes J., Roderick P.R., et al. Noninvasive markers of fibrosis in non-alcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 47 (2008) 455-460